HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Naphazoline

HCID 4436
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
10061-11-7
Standard SMILES
c1ccc2c(CC3=NCCN3)cccc2c1
InChIKey
CNIIGCLFLJGOGP-UHFFFAOYSA-N
Molecular formula
C14H14N2
Average molar mass
210.27 g/mol
Monoisotopic mass
210.11569846

Overview

2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole is a member of naphthalenes.

Names & identifiers

Preferred name
Naphazoline
IUPAC
2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole
English name
Naphazoline
Molecular formula
C14H14N2
Molecular weight
210.27

Names & synonyms

naphazoline835-31-42-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazoleNafazolinaClearineNafazolinNaphazolinum2-(1-Naphthylmethyl)-2-imidazolineCiba 2020/Ralpha-Naphthylmethyl imidazoline1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-DTXSID3048449
Show more names
NAPHAZOLINE HCLNAFAZOLINENaphazoline-d42-(1-NAPHTHYLMETHYL)-2-IMIDAZOLINE HYDROCHLORIDEAntanImidinPrivineSanorinRhinazineciba2020/r
H231GF11BVDTXCID90198485Tele StullnAK ConVasoconstrictor PensaPensa, VasoconstrictorRefChem:56335naphthizinum (for the nitrate)

Database identifiers

CAS
10061-11-7、835-31-4
PubChem CID
4436
DTXSID
DTXSID3048449
ChEMBL
CHEMBL761
ChEBI
CHEBI:93363
UNII

Properties

Computed structural propertiesFilling in

XLogP
2.1
Topological polar surface area
24.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
1
Rotatable bonds
2
Heavy atoms
16
Formal charge
0
Complexity
272

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Physical DescriptionSolid
Collision Cross Section · 2 items

149.6 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

147.59 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
254 °C · 254 °C
Boiling point
339.81 °C · 339.81°C (rough estimate)
Density
1.1063 · 1.1063 (rough estimate)
refractive index
1.618 · 1.6180 (estimate)
storage temp.
2 · 2-8°C
pka
10.35 · pKa 10.35 ± 0.02(H2O,t =25,Iundefined) (Uncertain)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 3 items

This chemical does not meet GHS hazard criteria for 100% (2 of 2) of all reports.

Not Classified

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory InformationREACH registered substance: Naphazoline (EC: 212-641-5)
Hazard Classes and CategoriesNot Classified

Safety data

wgk
3
rtecs
NJ4375000
ridadr
UN 2811 6.1/PG 2
risk_code
25
hazard_code
T
safety_code
45
REACH Registrations
Inactive

Chemistry & industry

Pharmacology

ATC Code · 6 items

R01AA08

S - Sensory organs

R - Respiratory system

R - Respiratory system

QR - Respiratory system

QR - Respiratory system

Protein BindingProtein binding data for naphazoline is unavailable.
PharmacodynamicsNaphazoline is a sympathomimetic alpha adrenergic agonist that acts to vasoconstrict nasal or ocular arterioles, resulting in reduced congestion at the site of administration.
Mechanism of Action · 1 item

Naphazoline is a vasoconstrictor that functions by stimulating alpha adrenergic receptors in arterioles leading to decreased congestion at the site of administration. Naphazoline causes the release of norepinephrine in sympathetic nerves. Norepinephrine binds to alpha adrenergic receptors and causes vasoconstriction. Naphazoline is also a mild beta adrenergic receptor agonist, which can cause rebound vasodilation after the alpha adrenergic stimulation has ended. Naphazoline's release of norepinephrine also triggers a negative feedback loop which decreases production of norepinephrine, which can lead to rhinitis medicamentosa after long term use when naphazoline is stopped.

Biological Half-LifeHalf life has not been determined but effects last for 4 to 8 hours. Other imidazoline compounds have half lives varying from 2 to 12 hours.
Metabolism/MetabolitesMetabolism data for naphazoline are scarce. Imidazoline compounds undergo some hepatic metabolism but a large fraction of the dose may be excreted unchanged in the urine.
MeSH Pharmacological Classification · 2 items

Drugs that selectively bind to and activate alpha adrenergic receptors.

Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
H231GF11BV
EC Number
212-641-5、233-197-9
Nikkaji
J7.133A
form
Solid
color
White to light yellow
CAS DataBase Reference
835 · 835-31-4(CAS DataBase Reference)
EWG's Food Scores
1 · 1-3
FDA UNII
231 GF11BV · H231GF11BV
ATC code
1 AA08,R01AB02,S01GA01,S01GA51 · R01AA08,R01AB02,S01GA01,S01GA51
NIST Chemistry Reference
Naphazoline(835-31-4)
Hazard Codes
T
Risk Statements
25 · 25
Safety Statements
45 · 45
RIDADR
2811 · UN 2811 6.1/PG 2
WGK Germany
3 · 3
RTECS
4375000 · NJ4375000
REACH Registrations
Inactive
Absorption, Distribution and Excretion · 4 items

Absorption data for naphazoline are scarce but imidazoline compounds in general are weakly basic and lipophilic, with high bioavailability from the gastrointestinal tract.

Imidazoline compounds undergo some hepatic metabolism but a large fraction of the dose may be excreted unchanged in the urine. Urinary excretion is higher with more acidic urine.

Distribution data for naphazoline are scarce but imidazoline compounds are distributed throughout the body, and can cross the blood-brain barrier.

Clearance data for naphazoline is unavailable.

Cellular LocationsMembrane

Uses & manufacturing

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan

Applications

UsesNaphazoline is used in severe rhinitis associated with colds, allergic reactions, and severe and chronic inflammatory conditions, in particular for inflammation of the antrum of Highmore as well as for stopping nosebleeds.

UsesAdrenergic (vasoconstrictor).

Upstream & downstream products

Upstream raw materials

MethanolEthanolEthylenediamine1-Naphthalenol, 4-methylbenzenesulfonate1-NaphthylacetonitrileETHYLENE DIAMINE TOSYLATEETHYLENEDIAMINE MONOHYDRATE1-Naphthaleneacetic acidMonoethanolamine

Downstream products

N-(2-AMINOETHYL)-2-(1-NAPHTHYL)ACETAMIDENaphazoline nitrate

Additional notes

DefinitionChEBI: 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole is a member of naphthalenes.